Gynecology and Obstetrics Clinic, Haydarpaşa Numune Training and Research Hospital, Istanbul
Abstract
Background: To evaluate the predictive role of a risk of malignancy index in discriminating between benign and malignant adnexal masses preoperatively. Materials and Methods: A total of 408 patients with adnexal masses managed surgically between January 2010 and February 2014 were included. The risk of malignancy indices (RMI) 1, 2, 3 and 4 were calculated using findings for ultrasonography, menopausal status, and CA125 levels. Histopathologic results were the end point. ROC analysis was used for the sensitivity and the specificity of the models. Results: Some 37.6 % of the cases were malignant in the postmenopausal group while 7.9 % were malignant in the premenopausal group. Pelvic pain was the most common complaint, and the majority of the cases were diagnosed at stage 3. The RMI 1, 2, 3 and 4 yielded percentage sensitivities of 76.1, 79.1, 76.1 and 76.1 and specificities of 91.5, 89.1, 90.6, 88.6, respectively. RMI 1 was the most reliable test in the general population according to AUC levels and Kappa statistics. From ROC analysis results of post/ premenopausal women, the RMI 1 (cut off: 200) yielded sensitivities of 84.0/60.9 and specificities of 87.7/92.5. With RMI 2 they were 88.6/60.9 and 80.0/91.0, with RMI 3 84.0/ 60.9 and 87.7/91.8, and with RMI 4 (cut off:400) 81.8/47.8 and 83.6 /44.0. Although test performance of RMI methods were good in a general population and postmenopausal women, the RMI inter-agreement validity was only moderate or fair in premenopausal women. Conclusions: Our study confirms the effectiveness of RMI algorithms in postmenopausal women. However, more sensitive tests are needed for premenopausal women.
Ertas, S., Vural, F., Tufekci, E., Ertas, A., Kose1, G., & Aka, N. (2016). Predictive Value of Malignancy Risk Indices for Ovarian Masses in Premenopausal and Postmenopausal Women. Asian Pacific Journal of Cancer Prevention, 17(4), 2177-2183.
MLA
Sinem Ertas; Fisun Vural; Ertugrul Can Tufekci; Ahmet Candost Ertas; Gultekin Kose1; Nurettin Aka. "Predictive Value of Malignancy Risk Indices for Ovarian Masses in Premenopausal and Postmenopausal Women". Asian Pacific Journal of Cancer Prevention, 17, 4, 2016, 2177-2183.
HARVARD
Ertas, S., Vural, F., Tufekci, E., Ertas, A., Kose1, G., Aka, N. (2016). 'Predictive Value of Malignancy Risk Indices for Ovarian Masses in Premenopausal and Postmenopausal Women', Asian Pacific Journal of Cancer Prevention, 17(4), pp. 2177-2183.
VANCOUVER
Ertas, S., Vural, F., Tufekci, E., Ertas, A., Kose1, G., Aka, N. Predictive Value of Malignancy Risk Indices for Ovarian Masses in Premenopausal and Postmenopausal Women. Asian Pacific Journal of Cancer Prevention, 2016; 17(4): 2177-2183.
)